Literature DB >> 2834676

Co-transmission in the rat vas deferens: postjunctional synergism of noradrenaline and adenosine 5'-triphosphate.

J P Huidobro-Toro1, S Parada.   

Abstract

In the isolated prostatic half of the rat vas deferens, joint application of noradrenaline (NA) and adenosine 5'-triphosphate (ATP) produced a contractile response whose magnitude was greatly larger than the addition of the tension generated by the application of each agent alone. The effect of ATP was mimicked by two non-hydrolyzable ATP analogs, but not by GTP, AMP or adenosine. In sympathectomized rats, ATP potentiated NA effects, increasing both the peak tension and the duration of the vas deferens contractile response. The synergism was concentration related. Prazosin antagonized the NA synergism but not the ATP response. Likewise, desensitization of the P2-purinoceptor blocked the ATP synergism without modifying the NA-induced contraction.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2834676     DOI: 10.1016/0304-3940(88)90589-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Adrenergic and purinergic components in bisected vas deferens from spontaneously hypertensive rats.

Authors:  M Guitart; J Giraldo; E Goñalons; E Vila; A Badia
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

2.  Purification and characterization of the inositol 1,4,5- trisphosphate receptor protein from rat vas deferens.

Authors:  R J Mourey; A Verma; S Supattapone; S H Snyder
Journal:  Biochem J       Date:  1990-12-01       Impact factor: 3.857

3.  Potentiation of purinergic transmission by angiotensin in prostatic rat vas deferens.

Authors:  C S Sum; D C Wan; W T Cheung
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

4.  Evans blue blocks P2X-purinoceptors in rat vas deferens.

Authors:  R Bültmann; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.